A detailed history of Magnus Financial Group LLC transactions in Immunome Inc. stock. As of the latest transaction made, Magnus Financial Group LLC holds 25,759 shares of IMNM stock, worth $234,664. This represents 0.04% of its overall portfolio holdings.

Number of Shares
25,759
Previous 25,759 -0.0%
Holding current value
$234,664
Previous $311,000 20.9%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

BUY
$16.33 - $32.33 $181,442 - $359,218
11,111 Added 75.85%
25,759 $446,000
Q1 2021

May 05, 2021

BUY
$9.56 - $43.24 $140,034 - $633,379
14,648 New
14,648 $496,000

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $110M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.